- Home
- BBIO vs VNT Comparison
BBIO vs VNT Comparison
Compare BBIO & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- VNT
- Stock Information
- Founded
- BBIO 2015
- VNT 2019
- Country
- BBIO United States
- VNT United States
- Employees
- BBIO N/A
- VNT 8000
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- VNT Industrial Machinery/Components
- Sector
- BBIO Health Care
- VNT Industrials
- Exchange
- BBIO Nasdaq
- VNT Nasdaq
- Market Cap
- BBIO 6.7B
- VNT 4.9B
- IPO Year
- BBIO 2019
- VNT N/A
- Fundamental
- Price
- BBIO $33.02
- VNT $32.91
- Analyst Decision
- BBIO Strong Buy
- VNT Buy
- Analyst Count
- BBIO 12
- VNT 7
- Target Price
- BBIO $52.64
- VNT $43.80
- AVG Volume (30 Days)
- BBIO 2.7M
- VNT 1.1M
- Earning Date
- BBIO 05-01-2025
- VNT 05-01-2025
- Dividend Yield
- BBIO N/A
- VNT 0.30%
- EPS Growth
- BBIO N/A
- VNT 13.64
- EPS
- BBIO N/A
- VNT 2.75
- Revenue
- BBIO $221,902,000.00
- VNT $2,979,000,000.00
- Revenue This Year
- BBIO $12.42
- VNT $2.65
- Revenue Next Year
- BBIO $123.19
- VNT $4.77
- P/E Ratio
- BBIO N/A
- VNT $11.93
- Revenue Growth
- BBIO 2285.27
- VNT N/A
- 52 Week Low
- BBIO $21.62
- VNT $31.22
- 52 Week High
- BBIO $39.47
- VNT $45.34
- Technical
- Relative Strength Index (RSI)
- BBIO 45.09
- VNT 37.41
- Support Level
- BBIO $35.77
- VNT $32.16
- Resistance Level
- BBIO $37.06
- VNT $34.88
- Average True Range (ATR)
- BBIO 1.46
- VNT 0.86
- MACD
- BBIO -0.01
- VNT 0.07
- Stochastic Oscillator
- BBIO 23.60
- VNT 36.25
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About VNT Vontier Corporation
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.